Shui‐Hong Zhou

Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo

Yang‐Yang Bao, Shui‐Hong Zhou, Zhong‐Jie Lu et al. · Oncology Reports · 2015 · 67 citations · Full text

Changing trends in the clinical features of laryngeal tuberculosis: a report of 19 cases

Ling Ling, Shui‐Hong Zhou, Shenqing Wang · International Journal of Infectious Diseases · 2009 · 59 citations · Full text

Expression of Glucose Transporter-1 and -3 in the Head and Neck Carcinoma – The Correlation of the Expression with the Biological Behaviors

Shui‐Hong Zhou, Shenqing Wang, Qiuliang Wu et al. · ORL · 2008 · 54 citations

Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.

Ying‐Ying Xu, Tingting Wu, Shui‐Hong Zhou et al. · PubMed · 2014 · 53 citations · Full text

Thus Apigenin, Oncology, Glut-1 Expression +13

Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer

Hang Yang, Jiang-Tao Zhong, Shui‐Hong Zhou et al. · Oncotarget · 2019 · 50 citations · Full text

Neck Cancer, Pathology, Biological Behavior +18